Acute myeloid leukemia (AML) is increasingly being recognized as a national health priority due to rising cases. Despite ...

Multidrug resistance proteins contribute to chemotherapy resistance in various cancers. Among them, the P-glycoprotein (P-gp) has been the most investigated. These works aim to evaluate the efficacy ...

The Houston Texans are no exception. Bleacher Report's Moe Moton published an article Saturday suggesting one move every team ...

The Houston Texans added a lot of new faces to their receiving corps this offseason. They acquired Christian Kirk from ...

The 24-year-old wide receiver was Houston's second-round pick in the 2022 draft and has 412 yards and a touchdown in his career ...

Indeed, a subtype of AML -- acute promyelocytic leukemia (APL) -- is already treated this way using a pair of drugs (all-trans retinoic acid and arsenic trioxide) that shove APL cells down the ...

For Shenderov, the disease in the spotlight is acute promyelocytic leukemia (APL), a rare subform of leukemia that affects the white blood cells. Only 800 Americans are diagnosed with it each year.

Acute promyelocytic leukemia (APL) is a rare and aggressive form of leukemia, a cancer that affects blood cells. It is caused by a genetic mutation where two genes, PML and RARA, mistakenly fuse ...

For instance, one type is called acute promyelocytic leukemia (APL), which occurs when genes from chromosomes 15 and 17 switch places, creating an abnormal gene. This gene prevents a type of white ...

The Acute Promyelocytic Leukemia drugs in development market research report provides comprehensive information on the therapeutics under development for Acute Promyelocytic Leukemia, complete with ...